NEDD8

NEDD8 Full Name

neural precursor cell expressed, developmentally down-regulated 8

NEDD8 Introduction

NEDD8 (neural precursor cell expressed, developmentally down-regulated 8) is a small protein of the ubiquitin-like family that is conjugated to other proteins through a dedicated enzymatic cascade, a process known as neddylation. Although NEDD8 is highly similar to ubiquitin in sequence and structure, its functions are specialized: its best-characterized targets are the cullin proteins, which serve as scaffolds for the largest family of ubiquitin E3 ligases in the cell, the cullin-RING ligases that control the destruction of proteins governing the cell cycle, DNA repair, and gene expression. Conjugation of NEDD8 to cullins activates these ligases by inducing a conformational change that promotes the recruitment of ubiquitin-charged E2 enzymes, so neddylation is effectively the master switch for a substantial fraction of all regulated protein degradation. The pathway is druggable: MLN4924 (pevonedistat), a small-molecule inhibitor of the NEDD8-activating enzyme, has been extensively evaluated in clinical trials for cancer and works by blocking cullin neddylation, which stabilizes substrates such as the CDK inhibitor p27 and triggers cell cycle arrest and apoptosis in tumor cells. Because neddylation is also required for normal cell division and for responses to DNA damage, the study of NEDD8 has illuminated how a single ubiquitin-like modifier orchestrates protein turnover across the proteome.

Figure 1. The structure of NEDD8.

Ubiquitin-Like Modifier and the Neddylation Enzymatic Cascade
NEDD8 is an 81-amino-acid protein that shares roughly 60% sequence identity with ubiquitin and folds into an almost identical three-dimensional structure.
Conjugation of NEDD8 to substrates proceeds through three enzymatic steps: activation by the NEDD8-activating enzyme (NAE, a heterodimer of NAE1 and UBA3), transfer to the conjugating enzyme UBC12, and ligation by one of several E3 enzymes, of which the DCNL family and RBX2 are the best characterized.
The principal substrates of neddylation are the cullin scaffolds of cullin-RING E3 ligases; conjugation occurs on a conserved lysine in the cullin C-terminal domain.
Neddylation of cullins induces a conformational rearrangement that releases the catalytic RING subunit, allowing the ligase to bind ubiquitin-loaded E2 enzymes and to polyubiquitinate its substrates.
Cullin-RING ligases, in turn, control the degradation of hundreds of regulatory proteins, including cyclins, cyclin-dependent kinase inhibitors, transcription factors, and components of signaling pathways.
The COP9 signalosome reverses neddylation by removing NEDD8 from cullins, creating a dynamic cycle that allows ligase activity to be switched on and off.
The NEDD8 gene is located on human chromosome 14, and the modifier is expressed in all tissues, reflecting its fundamental role in protein homeostasis.

Regulation of Protein Degradation, Cell Cycle Control, and Cancer Therapy
Because cullin-RING ligases destine key cell cycle regulators for destruction, neddylation is required for orderly progression through the cell cycle, particularly for the degradation of cyclin-dependent kinase inhibitors that must be removed as cells enter S phase.
Neddylation also supports DNA damage responses: cullin-RING ligases degrade checkpoint and repair proteins at the appropriate times, and inhibition of neddylation sensitizes cells to DNA-damaging agents.
The discovery that cancer cells depend heavily on cullin-RING ligase activity prompted the development of MLN4924 (pevonedistat), which blocks NAE and globally suppresses neddylation.
Treatment of tumor cells with pevonedistat stabilizes substrates such as p27 and Nrf2, induces DNA re-replication and apoptosis, and inhibits tumor growth in preclinical models of leukemia, lymphoma, and solid tumors.
Clinical trials have evaluated pevonedistat both alone and in combination with conventional chemotherapy, particularly in acute myeloid leukemia and myelodysplastic syndromes.
Beyond cancer, dysregulation of the neddylation cycle has been implicated in inflammation and in the biology of the COP9 signalosome, and the pathway continues to be explored as a therapeutic target in multiple disease settings.

Alternate Names for NEDD8

NEDD8; neural precursor cell expressed, developmentally down-regulated 8; Nedd 8; neddylin; ubiquitin-like protein Nedd8; NEDD-8; FLJ43224; MGC104393; MGC125896; MGC125897;